Chemotherapy-induced cognitive impairments: White matter pathologies

被引：23

作者：

Matsos, A. ^{[1
]}

Loomes, M. ^{[1
]}

Zhou, I. ^{[1
]}

Macmillan, E. ^{[1
]}

Sabel, I. ^{[1
]}

Rotziokos, E. ^{[1
]}

Beckwith, W. ^{[1
]}

Johnston, I. N. ^{[1
]}

机构：

[1] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia

来源：

CANCER TREATMENT REVIEWS | 2017年 / 61卷

关键词：

Cancer; Chemotherapy; White matter; Myelin; Corpus callosum and processing speed; CENTRAL-NERVOUS-SYSTEM; ACUTE LYMPHOBLASTIC-LEUKEMIA; BREAST-CANCER SURVIVORS; DEFAULT MODE NETWORK; PRIMARY CNS LYMPHOMA; LONG-TERM SURVIVORS; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; FUNCTIONAL CONNECTIVITY; LONGITUDINAL ASSESSMENT;

D O I：

10.1016/j.ctrv.2017.09.010

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Whilst chemotherapeutic agents show promising results in the amelioration of cancerous tumors, patients often experience cognitive disturbances associated with chemotherapy long after treatment has ceased. Research has suggested that the structural integrity of white matter fibres in the brain are susceptible to the harmful effects of chemotherapy. Post-chemotherapy, white matter tracts often display altered morphology with a reduction in glial cells such as oligodendrocytes. Demyelination, gliosis and leukoencephalopathy during or post chemotherapy is associated with changes in processing speed and IQ, Thus, understanding the relationship between chemotherapy, white matter damage and cognition is warranted. This review presents evidence for chemotherapy induced white matter damage highlighting the importance of implementing behavioral and pharmological strategies to prevent or reverse such acute toxicity in the brain. (C) 2017 Elsevier Ltd. All rights reserved.

引用

页码：6 / 14

页数：9

共 50 条

[21] Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
Starobova, Hana
Vetter, Irina
FRONTIERS IN MOLECULAR NEUROSCIENCE, 2017, 10
[22] Chemotherapy-induced cardiomyopathy
Yusuf, Syed Wamique
Ilias-Khan, Nasreen A.
Durand, Jean-Bernard
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2011, 9 (02) : 231 - 243
[23] Chemotherapy-induced cardiomyopathy
Angela Y. Higgins
Thomas D. O’Halloran
James D. Chang
Heart Failure Reviews, 2015, 20 : 721 - 730
[24] Chemotherapy-induced cardiomyopathy
Higgins, Angela Y.
O'Halloran, Thomas D.
Chang, James D.
HEART FAILURE REVIEWS, 2015, 20 (06) : 721 - 730
[25] Chemotherapy-induced thrombosis
Haddad, Tufia C.
Greeno, Edward W.
THROMBOSIS RESEARCH, 2006, 118 (05) : 555 - 568
[26] Chemotherapy-Induced Hepatotoxicity
Thatishetty, Ameet V.
Agresti, Nicholas
O'Brien, Christopher B.
CLINICS IN LIVER DISEASE, 2013, 17 (04) : 671 - +
[27] Chemotherapy-induced cognitive impairment: focus on the intersection of oxidative stress and TNFα
Rummel, Nicole G.
Chaiswing, Luksana
Bondada, Subbarao
St. Clair, Daret K.
Butterfield, D. Allan
CELLULAR AND MOLECULAR LIFE SCIENCES, 2021, 78 (19-20) : 6533 - 6540
[28] A Review on the Neuroprotective Effect of Berberine against Chemotherapy-induced Cognitive Impairment
Sahu, Kuleshwar
Singh, Sukhdev
Devi, Bhawna
Singh, Charan
Singh, Arti
CURRENT DRUG TARGETS, 2022, 23 (09) : 913 - 923
[29] Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events
Dias-Carvalho, Ana
Ferreira, Mariana
Ferreira, Rita
Bastos, Maria de Lourdes
Sa, Susana Isabel
Capela, Joao Paulo
Carvalho, Felix
Costa, Vera Marisa
ARCHIVES OF TOXICOLOGY, 2022, 96 (01) : 11 - 78
[30] Alterations of cerebellar white matter integrity and associations with cognitive impairments in schizophrenia
Chang, Xuebin
Jia, Xiaoyan
Wang, Yulin
Dong, Debo
FRONTIERS IN PSYCHIATRY, 2022, 13

← 1 2 3 4 5 →